News
The researchers, led by Dr Manjula Reddy, have identified a proofreading step in the construction of bacterial cell walls ...
HYDERABAD: A team of scientists at the CSIR–Centre for Cellular and Molecular Biology (CCMB), Hyderabad, led by Dr Manjula Reddy, has discovered a novel proofre ...
Hyderabad: Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad identified a crucial ...
A research team led by Dr. Manjula Reddy at Hyderabad’s Centre for Cellular and Molecular Biology (CCMB) has discovered a ...
A breakthrough study by scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, has uncovered a crucial mechanism in bacteria that could have far-reaching implications for ...
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The Company is developing a platform of novel drugs ...
A screening of global venom libraries, powered by artificial intelligence, uncovered dozens of "promising" new drug ...
AI scanned animal venom peptides and found 386 potential antibiotics. Most killed drug-resistant bacteria in tests and were ...
Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which ...
18d
Pharmaceutical Technology on MSNAlembic Pharmaceuticals acquires UTILITY therapeuticsA lembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam 185 mg tablets), a penicillin class antibacterial for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results